CNC vs CVS
Centene Corporation and CVS Health, both Healthcare
CVS Health is the larger company at $125B against $30B. Over the past year CNC returned +103% against +19% for CVS. The RyuScore puts CVS ahead, 54 against 27 out of 100.
| Figure | CNC | CVS |
|---|---|---|
| Last close | $65.37 | $86.18 |
| Market cap | $30B | $125B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 22.7 |
| Dividend yield | n/a | 3.2% |
| 1-year return | +103% | +19% |
| 5-year return | +3.9% | +20% |
| RyuScoresector-relative, 1–10 | 27/100 | 54/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 52% of the disclosed total.
CVS Health
Revenue of $106B in Q2 2026, net income $3.0B. Its largest reported line is Health Services, 42% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.